Friday, October 21, 2022

Cala Trio: non-clinical test results

September 1, 2022. Cala Health published the results of long term use of the Cala Trio for the treatment of Essential Tremors of the hand/forearm.  The study included 321 individuals who used the Cala Trio for at least 90 days between August 2019 through June 2021.

This study compared the before and after measurement of tremor amplitude in a 20 second postural hold.  59% of the group had a 50% reduction in the measured tremor amplitude power.  This compares favorably with the best pharmacological treatment of Essential Tremors.

Patients with severe tremors experienced the greatest reduction in their tremors from this treatment.

No significant habituation was observed in patients who use the Cala Trio for more than one year.

In a voluntary survey, patients reported improvements in three areas of activities of daily living: eating 74%, drinking 65%, writing 64%.  65% of the survey preferred treatment with the Cala Trio over both medication and surgical intervention.

The full paper can be found here

Caution: Beta Blockers and Atrioventricular Block

  Propranolol is a beta blocker and is the only drug approved by the FDA for the treatment of Essential Tremors. Beta blockers cause the hea...